Benzotriazine inhibitors of kinases

The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.

Saved in:
Bibliographic Details
Main Authors NORONHA GLENN, GONG XIANCHANG, CAO JIANGUO, RENICK JOEL, HOOD JOHN, ZHAO NINGNING, BARRETT KATHY, MAK CHI CHING, SOLL RICHARD, ZENG BINQI, GRITZEN COLLEEN, WRASIDLO WOLFGANG, MCPHERSON ANDREW, PATHAK VED PRAKASH, SPLITTGERBER UTE, DNEPROVSKAIA ELENA
Format Patent
LanguageChinese
English
Published 06.05.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.
AbstractList The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.
Author WRASIDLO WOLFGANG
SOLL RICHARD
DNEPROVSKAIA ELENA
MCPHERSON ANDREW
RENICK JOEL
GRITZEN COLLEEN
BARRETT KATHY
GONG XIANCHANG
PATHAK VED PRAKASH
ZHAO NINGNING
HOOD JOHN
SPLITTGERBER UTE
NORONHA GLENN
ZENG BINQI
MAK CHI CHING
CAO JIANGUO
Author_xml – fullname: NORONHA GLENN
– fullname: GONG XIANCHANG
– fullname: CAO JIANGUO
– fullname: RENICK JOEL
– fullname: HOOD JOHN
– fullname: ZHAO NINGNING
– fullname: BARRETT KATHY
– fullname: MAK CHI CHING
– fullname: SOLL RICHARD
– fullname: ZENG BINQI
– fullname: GRITZEN COLLEEN
– fullname: WRASIDLO WOLFGANG
– fullname: MCPHERSON ANDREW
– fullname: PATHAK VED PRAKASH
– fullname: SPLITTGERBER UTE
– fullname: DNEPROVSKAIA ELENA
BookMark eNrjYmDJy89L5WRQdkrNq8ovKcpMrMrMS1XIzMvITMosyS8qVshPU8jOzEssTi3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GBoYmRmbm5kaOxsSoAQDtQSiG
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN101426772A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN101426772A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:40:53 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN101426772A3
Notes Application Number: CN2005818660
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090506&DB=EPODOC&CC=CN&NR=101426772A
ParticipantIDs epo_espacenet_CN101426772A
PublicationCentury 2000
PublicationDate 20090506
PublicationDateYYYYMMDD 2009-05-06
PublicationDate_xml – month: 05
  year: 2009
  text: 20090506
  day: 06
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies TARGEGEN INC
RelatedCompanies_xml – name: TARGEGEN INC
Score 2.8402407
Snippet The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Benzotriazine inhibitors of kinases
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090506&DB=EPODOC&locale=&CC=CN&NR=101426772A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbEwsEhJs0jUNQbWr7omaSlmuomJSaa6qckp5magE4tS00DjHb5-Zh6hJl4RphFMDFmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdY7tjQwNTBTc3GydQ3wd_F3VnN2tnX2U_MLsgVdSWtkBmxKOjIzsAKb0Rag5X-uYU6gXSkFyFWKmyADWwDQtLwSIQamqgxhBk5n2M1rwgwcvtAJbyATmveKRRiUnVLzqvJBt2yADoRWyMzLyEzKBN2Vo5CfppCdmQesjopFGRTdXEOcPXSBtsXDvRbv7IdwmLEYAwuwy58qwaAA7AOZpACrTmDuTzYBNiCSzFMsjSxSks0sgcGaaGQuySCF2xwpfJLSDFyQ-RBTXQMzGQaWkqLSVFlgtVqSJAcODwDxU3uX
link.rule.ids 230,309,786,891,25585,76894
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSbEwsEhJs0jUNQbWr7omaSlmuomJSaa6qckp5magE4tS00DjHb5-Zh6hJl4RphFMDFmwvTDgc0LLwYcjAnNUMjC_l4DL6wLEIJYLeG1lsX5SJlAo394txNZFDdY7tjQwNTBTc3GydQ3wd_F3VnN2tnX2U_MLsgVdSWtkBmxKOjIzsAKb2Jagc_Zdw5xAu1IKkKsUN0EGtgCgaXklQgxMVRnCDJzOsJvXhBk4fKET3kAmNO8VizAoO6XmVeWDbtkAHQitkJmXkZmUCborRyE_TSE7Mw9YHRWLMii6uYY4e-gCbYuHey3e2Q_hMGMxBhZglz9VgkEB2AcySQFWncDcn2wCbEAkmadYGlmkJJtZAoM10chckkEKtzlS-CTlGTg9Qnx94n08_bylGbggcyOmugZmMgwsJUWlqbLAKrYkSQ4cNgDnmH6K
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Benzotriazine+inhibitors+of+kinases&rft.inventor=NORONHA+GLENN&rft.inventor=GONG+XIANCHANG&rft.inventor=CAO+JIANGUO&rft.inventor=RENICK+JOEL&rft.inventor=HOOD+JOHN&rft.inventor=ZHAO+NINGNING&rft.inventor=BARRETT+KATHY&rft.inventor=MAK+CHI+CHING&rft.inventor=SOLL+RICHARD&rft.inventor=ZENG+BINQI&rft.inventor=GRITZEN+COLLEEN&rft.inventor=WRASIDLO+WOLFGANG&rft.inventor=MCPHERSON+ANDREW&rft.inventor=PATHAK+VED+PRAKASH&rft.inventor=SPLITTGERBER+UTE&rft.inventor=DNEPROVSKAIA+ELENA&rft.date=2009-05-06&rft.externalDBID=A&rft.externalDocID=CN101426772A